Daniela Bellomo, TT Factor: Translating Knowledge into Patient Benefit




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Daniela Bellomo, TT Factor: Translating Knowledge into Patient Benefit
Released on: March 04, 2016. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    TTFactor is the technology transfer company for three of the leading oncology research institutions in Italy,.
  • Summary
  • Transcript
  • Participants
  • Company
TTFactor is the technology transfer company for three of the leading oncology research institutions in Italy,. Daniella Bellomo, Managing Director of TTFactor, explains their strategy for overcoming challenges, how they source projects from over 2500 clinicians and scientists, and partner the best of these projects with industry.
TTFactor is the technology transfer company for three of the leading oncology research institutions in Italy,. Daniella Bellomo, Managing Director of TTFactor, explains their strategy for overcoming challenges, how they source projects from over 2500 clinicians and scientists, and partner the best of these projects with industry.
TT Factor source their projects from over 2500 clinicians and scientists across 3 of italy's leading institutes. Their goal is to partner the best of these projects with industry. During BIO 2015, Daniella Bellomo, Managing Director explained how they overcome the challenges they face to PharmaVentures CEO, Fintan Walton.
TTFactor is the technology transfer company of the European Institute of Oncology (IEO) and the FIRC Institute for Molecular Oncology (IFOM) and so can source their projects from over 2500 clinicians and scientists . Their goal is to partner the best of these projects with industry. During BIO 2015, Daniella Bellomo, Managing Director explained how they overcome the challenges they face to PharmaVentures CEO, Fintan Walton.